WASHINGTON, Jan. 27-- Karen E. Weck, president of Association for Molecular Pathology, Rockville, Maryland, has issued a public comment on the Centers for Medicare and Medicaid Services's proposed ...

ROCKVILLE, Md. – June 6, 2024 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published a set of evidence-based recommendations for ...

ROCKVILLE, Md. – June 24, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations ...

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

Two medical oncologists break down the role molecular testing has when treating NSCLC, from guidelines to common methods to barriers. Joshua Sabari, MD: I recommend testing up front. All patients with ...

We reviewed electronic medical records of patients with newly diagnosed, untreated metastatic NSCLC from December 2018 to August 2021 and determined the number of days from pathologic diagnosis to NGS ...

ALBUQUERQUE, N.M. and EINDHOVEN, The Netherlands, April 17, 2023 /PRNewswire/ -- Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and ...

MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is ...